Avidity Biosciences
RNA
#1830
Rank
$10.82 B
Marketcap
$71.86
Share price
0.04%
Change (1 day)
115.21%
Change (1 year)

Avidity Biosciences (RNA) Fails to deliver data

Key failure to deliver metrics for Avidity Biosciences:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Avidity Biosciences (RNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Avidity Biosciences (RNA) - since 2020

Volume in USD (price x number of shares), data since 2020

Avidity Biosciences (RNA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025$45.12 M179.99%
2024$16.11 M267.16%
2023$4.38 M-91.34%
2022$50.7 M162.44%
2021$19.31 M-77.68%
2020$86.53 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
PTC Therapeutics
PTCT
$3.46 M$32.41 M๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
N/A$0.01 M๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
$1.79 M$20.7 M๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
$0.17 M$0.95 M๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
$0.59 M$1.38 M๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$29.26 M$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$61.56 M$0.39 B๐Ÿ‡ฌ๐Ÿ‡ง UK